WSJ Medical Group - Intelligent EtO Sterilization
U.S. Strategic Infrastructure

Redefining EtO Sterilization for the United States.

Protecting public health, reducing emissions, and preventing medical device shortages with a patented, AI-driven Automated Intelligent Ecosystem designed for absolute EPA compliance.

Request Strategy Call arrow_forward Regulatory Briefing download
Regulatory & Operational Pressure

The Litigation Crisis in U.S. Sterilization

Legacy facilities are failing to meet the EPA's updated NESHAP standards, leading to facility closures and massive liability exposure.

U.S. Risk Watchlist

Sterigenics SETTLED $408M

870+ lawsuits in Illinois settled regarding Willowbrook facility emissions.

Cosmed Group CHAPTER 11

Bankruptcy filing citing 300+ lawsuits and $100M+ in liabilities.

STERIS ACTIVE LITIGATION

275+ plaintiffs in Chicago claiming cancer from EtO exposure.

3M (Global) HIGH RISK

Legacy vertical copper vent systems causing worker exposure litigation.

Litigation & Compliance Cost Projection

warning PROTECTING THE U.S. MEDICAL SUPPLY CHAIN IS A NATIONAL PRIORITY.
Patented Automated Infrastructure
shield US PATENT #10,987,443 B1

Closed-loop architecture removes workers from contaminated zones entirely via AGV robotics.

The Solution

Automated Intelligent Ecosystem

Transition from legacy manual facilities to the first AI-driven hub that decouples human presence from hazardous gas zones. Our patented technology ensures zero fugitive emissions and 99.9% biological detoxification.

precision_manufacturing

AGV Robotics

Unmanned automated warehousing & handling.

biotech

Bio-Degradation

Induced non-pathogenic microbes ingest EtO.

history_edu

Regulatory Ready

FDA Part 11 & EPA NESHAP compliant logs.

energy_savings_leaf

Sustainable Hub

Garden-style infrastructure with eco-ponds.

Quantifiable Results

Investment & Operational Resilience

WSJ Medical Group provides infrastructure built for long-term regulatory resilience. By modernizing to our intelligent ecosystems, medical manufacturers protect their operational licenses and shareholder value.

Liability Insurance Premium Reduction ~35%
Facility ROI / Investment Recovery 2.5 Years
Worker Exposure Claims Exposure Zero-Risk

U.S. Deployment Strategy

"Securing terminal sterilization capacity for the next generation of American-made medical technology."

check_circle Fixed Automated Hubs
check_circle Mobile Containerized Units
FDA
VALIDATED PROCESS
EPA
NESHAP COMPLIANT
OSHA
ZERO EXPOSURE
ISO
11135 CERTIFIED

Secure Your Supply Chain Today

Protect your operations and the U.S. medical device infrastructure. Join the network of compliant, efficient sterilization leaders.

Regulatory Emergency Response: +1 (800) WSJ-MEDG

builderall []